| 2017 | Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis
| Translational and Clinical Pharmacology |
| 2014 | Effect of Ketoconazole on Lobeglitazone Pharmacokinetics in Korean Volunteers | CLINICAL THERAPEUTICS |
| 2022 | Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2017 | Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS |
| 2019 | Effects of Gelidium elegans on Weight and Fat Mass Reduction and Obesity Biomarkers in Overweight or Obese Adults: A Randomized Double-Blinded Study
| Nutrients |
| 2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2016 | Effects of JOINS® on the pharmacokinetic profiles of aceclofenac in healthy Korean volunteers: an open-label, multiple-dose, one sequence, two-period study
| Translational and Clinical Pharmacology |
| 2020 | Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2020 | Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects
| Translational and Clinical Pharmacology |
| 2023 | Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
| Translational and Clinical Pharmacology |
| 2010 | Extended-Spectrum β-Lactamase을 생성하는 Escherichia Coli 감염에 의한 패혈증 1예
| Korean Journal of Family Medicine (가정의학회지) |
| 2014 | First-in-human study with new recombinant agalsidase beta (ISU303) in healthy subjects | JOURNAL OF CLINICAL PHARMACOLOGY |
| 2013 | Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics | PHARMACOGENETICS AND GENOMICS |
| 2013 | Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans
| DRUG METABOLISM AND PHARMACOKINETICS |
| 2012 | Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2013 | Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2012 | Is abdominal obesity associated with the 2009 influenza A (H1N1) pandemic in Korean school-aged children? | INFLUENZA AND OTHER RESPIRATORY VIRUSES |
| 2020 | Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
| Translational and Clinical Pharmacology |
| 2023 | Pharmacokinetic and pharmacodynamic drug-drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
| Clinical and Translational Science |
| 2023 | Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects | Expert Opinion on Drug Metabolism & Toxicology |
